Posts In: Gubba Pharma In E News

Indian generic industry loses a titan in DG Shah

March 28, 2019 Gubba Pharma In E News

D G Shah had a larger imprint on the pharma industry than what his job title — secretary general of the Indian Pharmaceutical Alliance (IPA)...

Continue Reading

FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines

March 28, 2019 Gubba Pharma In E News

A key element of the U.S. Food and Drug Administration’s mission is focused on helping to ensure that all products we regulate, including drugs available...

Continue Reading

Glenmark Pharma appoints CEO for its new innovation company

March 28, 2019 Gubba Pharma In E News

Glenmark Pharmaceuticals has announced the appointment of Alessandro Riva as the CEO of its new innovation company.Mr. Riva is currently Executive Vice President, Oncology Therapeutics...

Continue Reading

US FDA chief’s exit could impact Indian pharma

March 28, 2019 Gubba Pharma In E News

The abrupt exit of the US FDA commissioner Scott Gottlieb after a nearly 2-year stint under the Trump administration throws Indian pharma into uncertainty on...

Continue Reading

India gets tough on generics quality issues and cancer drug prices

March 28, 2019 Gubba Pharma In E News

Even as more blood pressure drugs are being recalled in the USA after being found to contain trace amounts of a potentially cancer-causing ingredient, India’s...

Continue Reading

Suven plans to buy US-based Rising Pharmaceuticals’ assets

March 28, 2019 Gubba Pharma In E News

Suven Life Sciences through its joint venture partner, Shore Suven Pharma, has entered into a ‘stalking-horse’ asset purchase agreement to buy the assets of Aceto...

Continue Reading

USFDA lifts warning letter on Dr Reddy’s Duvvada plant in Andhra Pradesh

March 28, 2019 Gubba Pharma In E News

This is the second plant to come out of the warning letter after multiple inspections conducted by the US drug regulator. In a major relief to...

Continue Reading

Big relief for cancer patients: 30% margin on medicines to reduce prices, benefit poor

March 28, 2019 Gubba Pharma In E News

The healthcare industry has hailed the Modi government for capping 30 per cent margin on 42 drugs meant for the cancer patients. The industry insiders...

Continue Reading

Industry, regulator interaction needed for clarification on BA/BE submission norms

March 28, 2019 Gubba Pharma In E News

Even as the Central Drugs Standards Control Organisation (CDSCO) has set the ball rolling for BA/BE (bioavailability/ bioequivalence) submissions, the pharma and biotech industry in...

Continue Reading